Tjoapack launches new bottle packing line

Packaging & Labelling
Typography

Contract packaging organisation (CPO), Tjoapack, has launched its new bottle packing line following a major investment earlier this year.

The new line, which is now operational at its facility in Etten-Leur, the Netherlands, triples the CPO’s capacity using high-throughput technology and caters for the growing demand for bottle packing services in Europe.

Tjoapack, which specialises in primary packaging for solid dosage forms, unit dose packaging and secondary packaging, now has 19 packaging lines for blisters, wallets and bottles and supplies to customers in over 40 countries across Europe, North & South America, Asia and Africa.

Dexter Tjoa, director corporate strategy at Tjoapack said: “The investment has hugely increased our capacity, meaning we can now process 13,000 tablets per minute on our bottling lines. This will be of huge benefit to companies outsourcing their packaging requirements to us, particularly those in the generics market where reducing time to market, and therefore cost, is crucial.

“This investment allows us access to the latest packaging technologies and will help us to continue to improve supply chain efficiencies for our customers. As we move into 2018 we expect to see the demand for outsourced packaging solutions increase and we will continue to innovate and invest in both our capabilities and capacities.”

The new line is the latest part of an ongoing investment plan to allow the company to better serve a global customer-base by utilising the latest packaging innovations and creating a more efficient supply chain.

Founded in 1989, Tjoapack is an independent contract packager of medicines servicing clients across five continents. The CPO packages around 25 million packs of pharmaceutical products per year, which is equal to 1.3 billion tablets. With specialist expertise in track & trace, Tjoapack was the first company to perform full serialisation and aggregation on a packaging line from blister pack to pallet and its core goal continues to be to ensure a safer supply chain for patients.